Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone acetate versus dydrogesterone for abnormal uterine bleeding
IRCT20140111016161N7Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in menstrual disorders comparing Medroxyprogesterone acetate with Dydrogesterone (2 arms). Primary endpoints: Vaginal bleeding, Endometrial thickness and 1 more. Started Mar 2017; status: completed.
02
Drugs
medroxyprogesterone acetatedydrogesterone
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on IRCT20140111016161N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140111016161N7.